Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

DOI Full Paper Access

364

Citations

18

References

2014

Year

Sigrun Halvorsen, Dan Atar, H. Yang, R De Caterina, Çetin Erol, C. B. Granger, Michael G. Hanna, Claes Held, Steen Husted, Elaine M. Hylek,

European Heart Journal

Abstract

The benefits of apixaban vs. warfarin were consistent in patients with AF regardless of age. Owing to the higher risk at older age, the absolute benefits of apixaban were greater in the elderly.

References

	Year	Citations

Page 1